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OBJECTIVES We sought to determine the incidence of arteriovenous fistulas (AVF), identify risk factors for
AVF, and follow up the clinical outcome of femoral AVF.
BACKGROUND Arteriovenous fistulas are a potential harmful complication of cardiac catheterization.
Incidence and clinical outcome of iatrogenic AVF are unknown so far, although important for
risk stratification and treatment.
METHODS A total of 10,271 consecutive patients undergoing cardiac catheterization were followed up
prospectively over a period of three years. Diagnosis of AVF was performed by duplex
sonography.
RESULTS The incidence of AVF was 0.86% (n  88). The following significant and independent risk
factors for AVF were identified: high heparin dosage (odds ratio [OR])  2.88), coumadin
therapy (OR  2.34), puncture of the left groin (OR  2.21), arterial hypertension (OR 
1.86), and female gender (OR  1.84). Within 12 months 38% of all AVF closed
spontaneously. No signs of cardiac volume overload or limb damage were observed in patients
with persisting AVF. None of the risk factors for AVF influenced the incidence or the rate
of AVF closure. Only intensified anticoagulation showed a tendency to extend AVF
persistence.
CONCLUSIONS Almost 1% of patients undergoing cardiac catheterization acquire femoral AVF, for which
patient- and procedure-related risk factors could be identified. One-third of iatrogenic AVF
close spontaneously within one year. Cardiac volume overload and limb damage are highly
unlikely with AVF persistence. Thus, a conservative management for at least one year seems
to be justified. (J Am Coll Cardiol 2002;40:291–7) © 2002 by the American College of
Cardiology Foundation
Recent years have witnessed an exponential increase in the
number of diagnostic and interventional cardiac catheter-
izations with several million procedures performed world-
wide annually. The most common site to access the arterial
circulation is the femoral artery. Potential complications are
arteriovenous fistula (AVF), pseudoaneurysm, hemorrhage,
arterial thrombosis, and peripheral embolization. Previous
studies addressing the incidence of these iatrogenic compli-
cations were based on retrospective analyses of cohorts
referred to vascular surgery. The reported incidence of all
vascular complications ranged from 1% to 9%, and the
incidence of AVF varied from 0.006% to 0.14% (1–5).
However, as most of these retrospective analyses of surgical
data bases included only patients with operative repair of a
post-catheterization complication, they are not suitable to
prospectively determine the incidence and the clinical out-
come of iatrogenic AVF.
The clinical significance of AVF may result from hemo-
dynamic relevant left-to-right shunts. Potential side effects
of AVF are a reduced blood flow in the downstream vascular
bed and progressive heart failure due to cardiac volume
overload (6). It appears crucial to identify possible risk
factors for AVF, which may provide a rationale for effective
risk stratification in patients undergoing cardiac catheter-
ization. Furthermore, characterizing the clinical outcome of
iatrogenic AVF may help to define therapeutic strategies for
these patients. Thus, we conducted a three-year follow-up
study to estimate the incidence of AVF, identify risk factors
for AVF, and determine the clinical outcome of femoral
AVF.
METHODS
Study population. Within two years a total of 10,271
consecutive patients undergoing endovascular catheteriza-
tion were included in this prospective three-year follow-up
study. The study was performed in accordance with the
regulations of the local ethics committee and the declaration
of Helsinki. All patients were informed and gave oral/
written consent for endovascular catheterization. Patients
were excluded from this study for the following reasons: 1)
the patient refused to grant oral/written consent for exam-
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ination (n  3); 2) the arterial approach was performed via
the brachial artery (n  43); or 3) the patient was trans-
ferred to another hospital before removal of the sheaths
(n  3).
Cardiac catheterization. Puncture of the femoral artery
was performed by experienced investigators (600 proce-
dures per year) using a sheath size of 7 F for diagnostic
catheterization (n  7,186) and of 8 F for therapeutic
procedures (n  3,085). An additional 7-F venous sheath
was inserted in the femoral vein for all patients undergoing
interventional procedures or in whom simultaneous left-
and right-heart catheterization was performed. In patients
treated with coumadin, treatment was discontinued until an
international normalized ratio (INR) 1.8 was reached.
Unless contraindicated, all patients undergoing diagnostic
catheterization were treated with5,000 international units
(IU) of heparin, whereas 500 mg acetylsalicylic acid and
12,500 IU of heparin in a weight-adjusted mode were
applied during percutaneous coronary intervention (PCI).
Glycoprotein receptor blockers (GP) were given only rarely
at the time of study period (n  7). The sheaths were
removed approximately 1 h after diagnostic and 4 h after
interventional procedures if activated clotting time (ACT)
was 150 s. Local hemostasis was achieved by manual
compression for at least 15 min. If necessary, heparin was
re-administered 4 h after sheath removal. Thereafter, pa-
tients were kept down for 24 h before ambulating. Seventy-
nine of 88 patients with AVF received long-term treatment
with acetylsalicylic acid 100 mg/day.
Diagnosis and follow-up of AVF. All patients were rou-
tinely examined by the medical staff before and after
catheterization including auscultation of both groins. Spe-
cial attention was paid to the detection of a new continuous
femoral bruit (systolic/diastolic) on the day after sheath
removal. In case of clinical suspicion of a vascular compli-
cation (hematoma, pulsatile mass, atypical pain, vessel
thrombosis, or a new femoral bruit), a duplex scan was
performed. Duplex scans were acquired with a Hewlett-
Packard Sonos 2500 color Doppler sonography system,
which was also used to estimate shunt volume across
femoral AVF in a subset of patients with sufficient condi-
tions for quantitative ultrasound measurements (non-obese
subjects, without groin pain or hematoma after cardiac
catheterization, n 22). An AVF was diagnosed if all of the
following criteria were fulfilled: 1) a colorful “speckled” mass
at the level of the fistula with turbulent flow in the
arteriovenous connection; 2) increased venous flow more to
the proximal than the contralateral side of the fistula, with
a lack of respiratory variation and a pulsatile arterial com-
ponent in the affected vein; and 3) decreased arterial flow
distal to the suspected fistula. The study protocol did not
include the assessment of the incidence of pseudoaneurysm
or severe hematoma.
To estimate shunt volume, the diameter of the artery and
the mean blood flow velocity directly proximal to the fistula
were determined. Identical measurements were done on the
opposite side. The shunt volume was calculated as follows:
SV  BFAVF  BFnorm, where SV  shunt volume
[ml/min], BFAVF blood flow in the artery proximal to the
AVF [ml/min], BFnorm  blood flow in the normal con-
tralateral artery [ml/min]. Blood flow was calculated by the
formula: BF  (Vm    d2)/4)  h, where Vm  mean
blood flow velocity proximal to the AVF [cm/s],   3.14,
d  diameter of the artery proximal to the AVF [cm], hr 
heart rate [beats/min]. All patients in whom an AVF was
diagnosed underwent routine follow-up examinations. They
were scheduled for outpatient visits every three months,
which included: 1) an interview for potential cardiac and
peripheral symptoms of AVF and a physical examination; 2)
a duplex scan of the left and right femoral artery and vein;
and 3) an electrocardiogram (ECG) and an echocardio-
graphic recording in those patients in whom appropriate
scans of all cardiac chambers could be obtained.
Risk factors for incidence and persistence of AVF. At
the end of the study period the control group was estab-
lished by collecting data of 278 patients selected as a
representative random sample survey by picking every 35th
patient of the entire study population. The ratio of male to
female patients was comparable in the AVF (65% to 35%)
and the control group (74% to 26%). The following param-
eters were assessed: patient-related factors (age, gender,
weight, height, body mass index [BMI], arterial hyperten-
sion) and procedure-related factors (number and size of
used sheaths, puncture of right versus left groin, procedural
heparin dosage, and ongoing coumadin therapy after cath-
eterization). Single sheath denotes puncture of only one
femoral vessel, and double sheath denotes puncture of both
the femoral artery and vein. During follow-up, identical
patient- and procedure-related parameters were entered into
the computerized data base every three months. Immedi-
ately after diagnosis, patients were offered treatment by
either surgical repair of AVF, so far considered as a standard
procedure at our institution, or to enter follow-up of
non-interventional observation.
Abbreviations and Acronyms
ACT  activated clotting time
AVF  arteriovenous fistula/fistulas
BMI  body mass index
CI  confidence interval
ECG  electrocardiogram
F  French (catheter size of 0.3 mm/F)
I50  interquartile distance
INR  international normalized ratio
IU  international units
MHz  megahertz
OR  odds ratio
PCI  percutaneous coronary intervention
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Statistical analyses. The incidence of AVF is given as
percentage of all included patients. The data of metric
variables (age, weight, height, and BMI) are given as
median and interquartile distance (I50) because age showed
an asymmetrical distribution. To determine independent
risk factors for AVF, the Fisher exact test for univariate
analysis and a logistic regression model for multivariate
analysis were performed. For this purpose, metric variables
(age, BMI) and non-metric variables with more than two
categories (sheath size and procedural heparin dosage) were
transferred into dichotomized variables. The odds ratio
(OR) with 95% confidence interval (CI) was calculated to
determine the relative risk of each suspected risk factor.
Statistical significance was considered when the 95% CI of
the multivariate OR exceeded the value of 1. The incidence
and rate of AVF closures were analyzed by Kaplan-Meier
analyses and log-rank tests, respectively. Incidence of en-
largement of the right atrium (20 mm) and ventricle
(25 mm) were assessed by the McNemar test for dichot-
omized variables. The Wilcoxon matched pair test was used
to calculate statistical differences of the dimension of the left
atrium and ventricle before and after acquisition of AVF.
Statistical significance was considered at a p value of 0.05.
All statistical analyses were performed using the software
package SPSS 7.5.2.G.
RESULTS
The characteristics of the study population are given in
Table 1. In 88 of 10,271 patients an AVF was diagnosed.
Thus, overall incidence of AVF amounted to 0.86%. Arte-
riovenous fistulas were slightly more frequent after interven-
tional procedures than after diagnostic procedures (1.1% vs.
0.75%) (p  0.12). In a subset, shunt volume was estimated
to be in a range of 160 to 510 ml/min (median 
330 ml/min, n  22). Shunt volume was 310 ml/min (250
to 350) in closed AVF and 350 ml/min (160 to 510) in
persistent fistulas, respectively (p  NS).
To determine independent risk factors for AVF, the
representative control group and the AVF group were
compared, and the OR for patient- and procedure-related
parameters were calculated (Table 2). Female gender and
arterial hypertension significantly enhanced the risk for
AVF, whereas age and BMI had no impact. Procedure-
related risk factors for AVF were puncture of the left groin
and the intensity of anticoagulation. High procedural hep-
arin dosage (12,500 IU) and coumadin therapy were
identified as independent procedure-related risk factors for
AVF. In contrast, the size and number of sheaths used were
of no significant relevance (see Table 2).
During follow-up, 38% of all AVF closed spontaneously,
whereas AVF persisted in 62% of patients. Sixty-nine
percent of the spontaneous AVF closures took place in the
first four months, and all occurred within 12 months (n 
33), resulting in a median period to closure of three months
(Fig. 1). None of the risk factors for acquisition of an AVF
significantly influenced the incidence of closure (Table 3) or
the time to AVF closure (Table 4). However, a trend to
extended persistence of AVF became obvious with a high
procedural heparin dosage (p  0.065) and with coumadin
therapy (p  0.091). None of the patients with persistent
AVF experienced clinical symptoms of limb damage such as
reduced walking distance, soft pulse, pain, and restless or
cold legs. Furthermore, no significant signs of right heart
Table 1. Characteristics of the Study Population
Demographic
Data
Control Group (C)
Median (I50)
AVF Group
Median (I50)
Number (n) 278 88
Age (yrs) 61 (53–68) 63 (58–70)
Weight (kg) 78 (69–86) 76 (68–85)
Height (cm) 172 (166–178) 170 (164–176)
Body mass index,
kg  [(m2)1]
26 (24–28) 26 (24–29)
Demographic data of the patient groups with arteriovenous fistula (AVF) and without
(C). Values of metric parameters are presented as median plus interquartile distance
(I50).
Table 2. Potential Factors in the Incidence of AVF
Risk Factors Dichotomization
Univariate Analysis Multivariate Analysis
Significance
Odds Ratio
(95% CI) Significance
Odds Ratio
(95% CI)
Patient-related factors
Gender male vs. female 0.106 1.53 (0.92–2.55) 0.0314* 1.84 (1.06–3.20)
Age 60 vs. 61 yrs 0.14 1.49 (0.91–2.43) 0.3019 1.32 (0.78–2.22)
BMI† normal vs. obese 1.0 1.03 (0.61–1.72) 0.9026 1.04 (0.60–1.79)
Arterial hypertension normotensive vs. hypertensive 0.013 1.92 (1.15–3.22) 0.0221* 1.86 (1.09–3.17)
Procedure-related factors
Puncture site right groin vs. left groin 0.018 2.35 (1.19–4.66) 0.0362* 2.21 (1.05–4.65)
Sheath size 7 F vs. 8 F 0.035 1.74 (1.06–2.87) 0.8147 0.89 (0.33–2.39)
Number of sheaths single vs. double 0.53 1.20 (0.73–1.98) 0.5885 0.84 (0.45–1.58)
Procedural heparin dosage 12,500 IU 0.006 2.11 (1.25–3.57) 0.0361* 2.88 (1.07–7.73)
Coumadin therapy / 0.056 2.12 (1.01–4.44) 0.0354* 2.34 (1.06–5.18)
Significance of patient- and procedure-related risk factors for acquisition of an arteriovenous fistula (AVF). Univariate comparison of control (C) and AVF groups was done by
Fisher exact chi-square test; multivariate analysis was done by multivariate logistic regression (CI  confidence interval). *Significant difference between C and AVF. †Body mass
index (BMI) was dichotomized according to the gender-specific reference values (cutoff points for BMI: 27.8 and 27.3 for male and female patients).
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failure were observed, that is, occurrence of right bundle
branch block, changes of heart axis in electrocardiographic
recordings, or echocardiographic signs of right ventricular
enlargement. The left heart dimensions before/after AVF
acquisition were as follows: 42  7 / 43  8 for left atrium
(p  NS), and: 53  3 / 54  9 for left ventricle (p  NS).
The percentage distributions of right atrial and ventricular
dilation before/after AVF acquisition were 9%/18% and
12%/9%, respectively (p  NS).
DISCUSSION
The present study is the first to investigate prospectively the
incidence and clinical outcome of iatrogenic femoral AVF
in a large number of consecutive patients. The major
findings of this study are as follows: 1) the overall incidence
of femoral AVF after cardiac catheterization approximates
1%; 2) independent patient- and procedure-related factors
for AVF could be identified, facilitating risk stratification;
3) 38% of all AVF closed spontaneously within one year; 4)
no severe local or systemic side effects were observed with
AVF persistence, which may be of importance for future
treatment of iatrogenic AVF.
Incidence of AVF. The incidence of iatrogenic AVF
found in this large prospective scale study (0.86%) corrob-
orates the data reported in two small prospectively designed
studies. In accordance with our protocol, patients in the
study of Kent et al. were routinely examined by the medical
staff for a new femoral bruit after cardiac catheterization,
followed by a duplex scan. The authors diagnosed six new
AVF in 1,838 consecutive patients (0.3%) (7). Using pri-
mary duplex scanning, Kresowik diagnosed four new AVF
in only 144 patients, resulting in an incidence of 2.8% (8).
As expected, the incidence of AVF was slightly higher with
primary duplex scanning than with primary clinical exami-
nation. Thus, in our study population the ultrasound-
guided detection of AVF might have revealed a somewhat
higher incidence of AVF. However, this could not be
performed, because our several-fold larger sample size did
not allow routine duplex scanning in every out of the 10,271
patients. Using the approach of combined clinical examina-
tion and consecutive duplex scanning, we could identify 88
patients with iatrogenic AVF, which is by far the largest
sample size studied so far. Only this large sample size
enables one to perform statistical analysis that will reliably
identify risk factors for the acquisition of AVF.
Arterial hypertension and female gender could be iden-
tified as independent, patient-related risk factors. The
driving force of elevated blood pressure together with the
hypertension-associated increase of vascular stiffness might
promote development of an AVF during puncture or sheath
removal. A possible explanation for the higher risk of AVF
in women is that their smaller vascular diameter could
require more punctures to achieve arterial access, which in
turn might lead to a higher incidence of AVF. However, we
Figure 1. Rate of persistence of arteriovenous fistula (AVF). The time
interval from acquisition to closure of AVF was analyzed by Kaplan-Meier
analysis. Numbers in horizontal bar indicate the cumulative number of
patients with AVF closure.
Table 3. Potential Determinants of the Incidence of Spontaneous AVF Closures in Patients
With Iatrogenic Femoral AVF (n  88)
Parameter Category AVF Closure p Value
Patient-related factors
Gender Male vs. female 35% vs. 38% 0.9425
Age 60 vs. 61 yrs 38% vs. 35% 0.7466
Body mass index normal vs. obese 31% vs. 46% 0.2501
Arterial hypertension normotensive vs. hypertensive 32% vs. 37% 0.6394
Procedure-related factors
Puncture site right vs. left groin 35% vs. 40% 0.8242
Sheath size 7 F vs. 8 F 31% vs. 42% 0.3824
Number of sheaths arterial vs. arterial and venous 29% vs. 40% 0.3582
Procedural heparin dosage 12,5000 IU 32% vs. 43% 0.4475
Coumadin therapy / 36% vs. 36% 0.7946
AVF  arteriovenous fistula.
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cannot prove this hypothesis definitely, because we did not
document the number of attempts to puncture. An in-
creased frequency of females and of arterial hypertension
have also been reported for the incidence of other post-
catheterization complications such as hemorrhage and pseu-
doaneurysm of the femoral artery (9). Aortic regurgitation is
frequently associated with increased systolic pressure and
altered mechanical properties of the arterial wall due to
widening of the blood pressure amplitude. In our cohort,
only two individuals of the AVF group had aortic regurgi-
tation. Because of the limited number of patients, we cannot
prove that aortic insufficiency may have led to an increased
rate of incidence or persistence of AVF.
Procedure-related risk factors were the mode and inten-
sity of anticoagulation and the site of access. A puncture of
the left groin was associated with more than a twofold risk
of acquiring an AVF. All of the investigators were right-
handed and performed the procedures from the patient’s
right-hand side. Thus, puncturing the left instead of the
right groin alters the accustomed angle of needle to vessel
and may provoke the simultaneous puncture of femoral
artery and vein, facilitating the development of AVF. High
heparin dosage and coumadin therapy increased risk of AVF
by more than twofold. An intensified anticoagulation thus
promotes development of AVF as was reported for post-
procedural false aneurysm and hemorrhage (10). Hence
using a lower INR threshold might reduce the incidence of
this complication.
The patient’s age, obesity, size, and number of used
sheaths did not predict for an increased frequency of
iatrogenic AVF. This contrasts strikingly with previous
observations indicating that these parameters represent
significant predictors for the incidence of false aneurysm
and uncontrolled hemorrhage (10). Thus, in the present
study, specific risk factors for the acquisition of an iatrogenic
AVF could be identified, whereas others could be ruled out,
and these factors are different from those reported for local
hematoma and aneurysm. Therefore, female individuals
with arterial hypertension, a need for intensified anticoag-
ulation, and puncture on the left groin have to be stratified
as patients at high risk of acquiring an AVF during cardiac
catheterization.
Clinical outcome of AVF. To date, no data exist that
predict the outcome of iatrogenic femoral AVF, that is, the
probability of spontaneous closure and the period until
closure. In the present study, one-third of all AVF closed
spontaneously within one year, and the majority closed even
more rapidly—within the first four months after acquisition
of AVF. Neither the incidence nor the rate of AVF closure
was significantly influenced by the risk factors for AVF.
Only with high heparin dosage and coumadin therapy was
a trend toward prolonged persistence observed. This finding
is most likely explained by a reduced thrombus formation, a
key event in the closure of AVF. In none of the patients
with persistent AVF were clinical signs of limb damage or
right heart failure observed. Left-to-right shunts at the level
of the atrial or interventricular septum deteriorate right
heart function only, when shunt volume exceeds 30% of
cardiac output. In a subset of our study population, shunt
volume was estimated in the range of 160 to 510 ml/min.
This is far below significant left-to-right heart shunts and
considerably lower than dialysis shunts (11) and thus un-
likely to exert detrimental effects on the heart. It has been
postulated from dialysis studies that with decreasing flow
volume (500 ml/min) (11) the probability of shunt closure
increases. Using ultrasound techniques we were able to
reliably quantitate shunt volume only in some but not all
patients with AVF. Thus, we could not specify the impact
of shunt volume on the persistence of AVF.
In view of these findings, therapeutic approaches for
patients with persistent iatrogenic AVF deserve re-
evaluation. Three different therapeutic strategies have been
recommended so far to close femoral iatrogenic AVF:
surgical repair, implantation of covered stents, and
ultrasound-guided compression. Although a rather low
efficacy for successful compression of AVF has been re-
ported (12,13), it should be applied as first-line therapy
because of its non-invasive nature. Implantation of stents
Table 4. Potential Determinants of the Incidence of Time to Closure of AVF in Patients With
Iatrogenic Femoral AVF (n  88)
Parameter Category Time to Closure p Value
Patient-related factors
Gender Male vs. female 3.1 (2.0–4.2) vs. 4.8 (2.8–6.7) 0.102
Age 60 vs. 61 yrs 3.9 (2.1–5.8) vs. 3.6 (2.4–4.9) 0.973
Body mass index normal vs. obese 3.4 (1.9–4.9) vs. 4.2 (3.0–5.5) 0.583
Arterial hypertension normotensive vs. hypertensive 3.6 (1.9–5.3) vs. 3.8 (2.5–5.1) 0.801
Procedure-related factors
Puncture site right vs. left groin 3.6 (2.4–4.8) vs. 4.2 (2.2–6.1) 0.629
Sheath size 7 F vs. 8 F 3.1 (2.0–4.2) vs. 4.4 (2.6–6.2) 0.180
Number of sheaths arterial vs. arterial and venous 3.3 (1.8–4.9) vs. 3.9 (2.6–5.2) 0.539
Procedural heparin dosage 12,5000 IU 3.0 (2.1–3.9) vs. 4.8 (2.8–6.9) 0.065
Coumadin therapy / 3.2 (2.2–4.3) vs. 6.9 (4.2–9.5) 0.091
Note that only high heparin dosage and coumadin therapy tend to prolong arteriovenous fistula (AVF) persistence. “Time to
closure” is given in months (median and range).
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into the common femoral artery represents an approach
currently under clinical investigation (14). The limited
number of patients studied, the potential likelihood of
restenosis, and stent failure due to repetitive movements in
the groin region prevent a final evaluation of this therapeutic
alternative so far (15,16). Based on studies of the natural
history of significant inborn or traumatic fistulas, surgical
repair has frequently been recommended for patients with
iatrogenic AVF (3). This therapeutic approach is hampered
by a considerable perioperative mortality and postoperative
complication rate (17). Thus, in light of our findings,
surgical repair should be recommended only cautiously, and
patients with persistent femoral iatrogenic AVF should
initially be managed non-operatively and followed up clin-
ically with duplex scans.
Study limitations. We have no data documented regarding
the number of previous catheterizations performed in each
patient. Thus, we cannot rule out whether a pre-punctured
groin might be more susceptible for AVF. Particularly, the
formation of connective and scar tissue that results from
repetitive puncture might lead to an atypical anatomy of
artery and vein and thus promote AVF development.
In the present study, arterial puncture was performed by
experienced investigators, usually distal to the inguinal
ligament and proximal to the bifurcation of femoral arteries.
In this area, the femoral artery and vein are clearly separated
from each other. At more peripheral access sites, the deep
femoral vein lies inferior to the artery (18). Thus, with more
distal access sites, the probability of puncturing artery and
vein, thereby simultaneously facilitating the development of
iatrogenic AVF, increases (19,20). Because we did not
perform duplex scanning of the groin routinely in all
patients before cardiac catheterization, we can estimate
neither the influence of access site along the common
femoral artery nor the incidence of topographic abnormal-
ities as a potential cause for the acquisition of a femoral
iatrogenic AVF.
After the study period, a slight downsizing of arterial
sheaths for cardiac catheterization occurred. Presently some
catheterization laboratories are using 5 F and 7 F
sheaths for diagnostic and interventional procedures, in-
stead of 7 F and 8 F sheaths as we used. The size of
sheaths may be an important determinant of the inci-
dence and extent of post-procedural hemorrhage and
false aneurysm. However, in our analysis the incidence
and outcome of AVF was independent from the number
and size of sheaths used, indicating that a further
downsizing of sheaths would not necessarily have altered
our results.
The majority of our patients were treated with acetylsal-
icylic acid, but only a minority with GP IIb/IIIa inhibitors.
Therefore, the heparin dosages used were somewhat higher
than those recommended currently. Whether or not inten-
sified antithrombotic therapy in addition to ACT-adjusted
anticoagulation with heparin, at least during PCI, may alter
the incidence and persistence of AVF in the future, deserves
further studies.
Conclusions. One-third of iatrogenic AVF close sponta-
neously within one year, and cardiac volume overload and
limb damage are highly unlikely with AVF persistence;
therefore, a conservative management for at least one year
seems to be justified.
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